August 13, 2024 / 13:28 IST
Reported Standalone quarterly numbers for Indo US Bio-Tech are:Net Sales at Rs 24.72 crore in June 2024 up 29.12% from Rs. 19.14 crore in June 2023.
Story continues below Advertisement
Quarterly Net Profit at Rs. 3.17 crore in June 2024 up 33.52% from Rs. 2.37 crore in June 2023.
EBITDA stands at Rs. 3.72 crore in June 2024 up 23.18% from Rs. 3.02 crore in June 2023.
Indo US Bio-Tec EPS has decreased to Rs. 1.58 in June 2024 from Rs. 2.37 in June 2023.
Indo US Bio-Tec shares closed at 219.10 on August 12, 2024 (BSE) and has given -8.61% returns over the last 6 months and 27.76% over the last 12 months.
| Indo US Bio-Tech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 24.72 | 15.77 | 19.14 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 24.72 | 15.77 | 19.14 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 0.13 | 0.20 | 1.08 | | Increase/Decrease in Stocks | 5.30 | -25.70 | 5.51 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.29 | 0.20 | 0.32 | | Depreciation | 0.20 | 0.20 | 0.20 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 15.31 | 40.10 | 9.25 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 3.49 | 0.77 | 2.79 | | Other Income | 0.03 | 0.21 | 0.03 | | P/L Before Int., Excpt. Items & Tax | 3.52 | 0.98 | 2.82 | | Interest | 0.33 | 0.36 | 0.37 | | P/L Before Exceptional Items & Tax | 3.19 | 0.63 | 2.45 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 3.19 | 0.63 | 2.45 | | Tax | 0.02 | 0.11 | 0.07 | | P/L After Tax from Ordinary Activities | 3.17 | 0.52 | 2.37 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 3.17 | 0.52 | 2.37 | | Equity Share Capital | 20.05 | 20.05 | 10.03 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.58 | 0.26 | 2.37 | | Diluted EPS | 1.58 | 0.26 | 2.37 | | EPS After Extra Ordinary | | Basic EPS | 1.58 | 0.26 | 2.37 | | Diluted EPS | 1.58 | 0.26 | 2.37 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
